Michael Mather

Dr. Michael Mather is a clinical academic researcher at Newcastle University's Faculty of Medical Sciences, specializing in otolaryngology with a particular focus on pediatric ear conditions. His research spans otitis media, otitis externa, mastoiditis, and hearing disorders, with significant contributions to understanding infectious processes and immune responses in these conditions.

Dr. Mather's research interests center on pediatric otolaryngology, particularly the diagnosis, management, and pathophysiology of ear infections. His work bridges basic science with clinical application, frequently employing systematic reviews, meta-analyses, and mixed-methods approaches to address clinical challenges. He has made significant contributions to understanding antimicrobial resistance patterns in pediatric otitis media, the development of physiological models of middle ear epithelium, and the complex immune responses in both infectious and viral-mediated ear conditions.

Analysis of Dr. Mather's recent publications reveals a consistent focus on evidence-based approaches to pediatric ENT conditions, with particular emphasis on antimicrobial stewardship, diagnostic accuracy, and optimizing patient care pathways. His work increasingly incorporates immune profiling and multi-omics approaches to understand the pathophysiology of ear conditions, reflecting the growing integration of basic science with clinical ENT practice.

• A Systematic Review and Meta-Analysis of the Efficacy of Antimicrobial Chemoprophylaxis for Recurrent Acute Otitis Media in Children (2025)
• A systematic review of SARS-CoV-2 associated sudden onset sensorineural hearing loss (2025)
• The utility of a symptom model to predict the risk of oesophageal cancer (2023)

Dr. Mather has collaborated extensively with colleagues across Newcastle University, including Emerita Professor Janet Wilson, Dr. Ben Talks, and Professor Muzlifah Haniffa. His collaborative network spans both clinical and basic science departments, facilitating translational research approaches. His laboratory and team work appears focused on clinical research rather than wet-lab experimentation, with emphasis on patient-centered outcomes, systematic reviews, and clinical pathway analysis.